Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-11 Purchase | 2021-06-15 4:02 pm | Atara Biotherapeutics Inc. | ATRA | Yarema Kristin Chief Commercial Officer | 34,354 | $14.57 | $500,370 | 125,882 (Direct) | View |
| 2021-05-18 Sale | 2021-05-20 4:29 pm | Atara Biotherapeutics Inc. | ATRA | Yarema Kristin Chief Commercial Officer | 761 | $14.55 | $11,073 | 91,528 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 4:03 pm | N/A 2034-01-01 | Poseida Therapeutics Inc. | PSTX | Yarema Kristin President and CEO | 595,200 | $0 | 952,036 (Direct) | View |
| 2023-04-11 Option Award | 2023-04-12 4:49 pm | N/A 2033-04-10 | Poseida Therapeutics Inc. | PSTX | Yarema Kristin President, Cell Therapy | 855,161 | $0 | 855,161 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 7:02 pm | N/A 2032-02-28 | Atara Biotherapeutics Inc. | ATRA | Yarema Kristin Chief Commercial Officer | 131,125 | $0 | 257,007 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 5:15 pm | N/A 2031-02-28 | Atara Biotherapeutics Inc. | ATRA | Yarema Kristin Chief Commercial Officer | 87,883 | $0 | 145,151 (Direct) | View |
| 2020-03-01 Option Award | 2020-03-03 5:00 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Yarema Kristin Chief Commercial Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-19 8:53 pm | N/A 2030-02-17 | Atara Biotherapeutics Inc. | ATRA | Yarema Kristin Chief Commercial Officer | 110,000 | $0 | 110,000 (Direct) | View |